There have been multiple accounts created with the sole purpose of posting advertisement posts or replies containing unsolicited advertising.
Accounts which solely post advertisements, or persistently post them may be terminated.
quindraco , 11 months ago The drugs that made the price negotiation cut are Johnson & Johnson’s Imbruvica, Stelara, and Xarelto, plus Bristol Myers Squibb’s Eliquis, Merck & Co.’s Januvia, Novartis’s Entresto, Eli Lilly’s Jardiance, AstraZeneca’s Farxiga, Novo Nordisk’s Fiasp, and Amgen’s Enbrel.
The drugs that made the price negotiation cut are Johnson & Johnson’s Imbruvica, Stelara, and Xarelto, plus Bristol Myers Squibb’s Eliquis, Merck & Co.’s Januvia, Novartis’s Entresto, Eli Lilly’s Jardiance, AstraZeneca’s Farxiga, Novo Nordisk’s Fiasp, and Amgen’s Enbrel.